These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5617977)

  • 21. Antipertussis immune response after 2 and after 3 doses respectively of diphtheria-tetanus-pertussis trivaccine.
    Andreescu V; Caffé I; Marion M; Ivan I; Cuteanu I; Barbu I
    Arch Roum Pathol Exp Microbiol; 1981; 40(3):253-7. PubMed ID: 6277273
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antibody response to the fractionated administration of the 2d or 3d basic vaccination injection with a mixed vaccine against diphtheria, tetanus and pertussis].
    Vodicková M; Svandová E
    Cesk Pediatr; 1986 Jun; 41(6):321-3. PubMed ID: 2872973
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccines and immunization schedules.
    Nagel J
    Trop Geogr Med; 1985 Sep; 37(3):S42-9. PubMed ID: 2866613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization. Around the world in 80 shots.
    Lange WR; Kreider SD
    Postgrad Med; 1983 Feb; 73(2):219-26. PubMed ID: 6823457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leads from the MMWR. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures.
    JAMA; 1985 Aug 23-30; 254(8):1009-11, 1014-6. PubMed ID: 3874970
    [No Abstract]   [Full Text] [Related]  

  • 26. [The duration and intensity of antitoxic tetanus immunity in children inoculated with combined vaccines].
    Maksimova NM; Basova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Aug; (8):118-23. PubMed ID: 4450866
    [No Abstract]   [Full Text] [Related]  

  • 27. [Characteristics of specific immunity in children vaccinated with AKDS-vaccine at increased intervals between vaccinations].
    Veĭsfeĭler OIu; Perel'shteĭn NN; Aleksina SG; Koval'skaia SIa; Braginskaia VP
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Apr; 51(4):36-9. PubMed ID: 4830390
    [No Abstract]   [Full Text] [Related]  

  • 28. [Possibilities and limits of vaccinations].
    Schneeweiss B
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):485-95. PubMed ID: 5114862
    [No Abstract]   [Full Text] [Related]  

  • 29. [Characteristics of cellular immune reactions in animals vaccinated with smallpox and ADPT vaccines].
    Romanov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jul; (7):82-5. PubMed ID: 6969014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
    Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
    Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [On the epidemiologic effectiveness of anti-pertussis immunization].
    Raĭkhshtat GN; Sumarokov AA; Shapiro AA; Riumina MG; Leĭkina RF; Berlovich EA
    Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):59-61. PubMed ID: 5733719
    [No Abstract]   [Full Text] [Related]  

  • 32. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Immunization Practices Advisory Committee.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jul; 34(27):405-14, 419-26. PubMed ID: 3925316
    [No Abstract]   [Full Text] [Related]  

  • 33. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J; Daft A; Samuelson J; Polin RA
    Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Reactions to vaccination and serologic response to the pertussis component of diphtheria-tetanus-pertussis (DiTePer) vaccines in children].
    Adonajlo A; Plucińska E; Kozerska D; Czopik A; Rodkiewicz T; Jaworski Z; Kolloto-Szymajda B; Wagner K; Walter T
    Przegl Epidemiol; 1972; 26(4):453-64. PubMed ID: 4680437
    [No Abstract]   [Full Text] [Related]  

  • 35. [Convulsive syndrome activation in mice after administration of ADPT vaccine].
    Kozal'skaia SIa; Ozeretskovskiĭ NA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jan; (1):73-7. PubMed ID: 7376761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experiences with newly developed cholera and diphtheria-tetanus-pertussis vaccines.
    Csizer Z; Boszormenyi J; Joo I
    Niger Med J; 1979; 9(7-8):651-6. PubMed ID: 543292
    [No Abstract]   [Full Text] [Related]  

  • 37. Diphtheria and tetanus toxoids and pertussis vaccine. Recommendations of the Public Health Service advisory committee on immunization practices.
    Ann Intern Med; 1972 Feb; 76(2):289-91. PubMed ID: 5009596
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunization of children who have received fractional doses of diphtheria-tetanus toxoids-pertussis vaccine.
    Pediatr Infect Dis J; 1989 Feb; 8(2):129-30. PubMed ID: 2704606
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative study of the reactogenicity of DTP vaccine, DT and modified DT anatoxins in revaccinating 6-year-old children].
    Barginskaia VP; Aleksina SG; Zybina TM; Shabad AT; Braĭnina RA
    Zh Mikrobiol Epidemiol Immunobiol; 1978 May; (5):140-2. PubMed ID: 208331
    [No Abstract]   [Full Text] [Related]  

  • 40. Leads from the MMWR. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures.
    JAMA; 1985 Aug; 254(7):895-7, 900. PubMed ID: 3874969
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.